Commentary

Effectiveness of sibutramine


 

References

Given the known problems with other anorexiant drugs (eg, fenfluramine and dexfenfluramine) and the expense of sibutramine, clinicians should demand evidence of true clinical benefit and long-term safety before routinely prescribing sibutramine for treating obesity.

Eric A. Jackson, PharmD
J. Herbert Stevenson, MD
Thomas Trojian, MD
University of Connecticut School of Medicine and
Saint Francis Hospital and Medical Center
Hartford, Connecticut
E-mail: ejackson2@stfranciscare.org

Pages

Recommended Reading

Obesity Management in Primary Care Changing the Status Quo
MDedge Family Medicine
Randomized Placebo-Controlled Trial of Long-Term Treatment with Sibutramine in Mild to Moderate Obesity
MDedge Family Medicine
Weight Management: What Patients Want from Their Primary Care Physicians
MDedge Family Medicine
What is the long-term efficacy and tolerability of orlistat, a gastrointestinal lipase inhibitor, for the treatment of obesity in primary care?
MDedge Family Medicine